Adocia SA ADOIF:Grey Market

RT Quote | Exchange | USD
Last | 12/28/20 EST
10.14UNCH (UNCH)
52 week range
10.03 - 10.25

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close10.14
  • 52 Week High10.25
  • 52 Week High Date12/22/20
  • 52 Week Low10.03
  • 52 Week Low Date12/14/20
  • Market Cap90.2M
  • Shares Out6.95M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Adocia SA News

There is no recent news for this security.

Latest ADOIF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Adocia SA is a clinical-stage biotechnology company based in France. The Company specializes in the development of formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary technological platform BioChaperone is designed to enhance the effectiveness and/or safety of therapeutic proteins while making them easier for patients to use. The Company’s clinical pipeline includes four novel insulin...
Gerard Soula
Chairman
Valerie Danaguezian
Chief Financial Officer
Address
115 avenue Lacassagne
Lyon
69003
France